%D9%88%D8%B1%D9%85_%D8%A3%D8%B1%D9%88%D9%85%D9%8A_%D9%86%D8%AE%D8%A7%D8%B9%D9%8A%E0%A6%AE%E0%A7%87%E0%A6%A1%E0%A7%81%E0%A6%B2%E0%A7%8B%E0%A6%AC%E0%A7%8D%E0%A6%B2%E0%A6%BE%E0%A6%B8%E0%A7%8D%E0%A6%9F%E0%A7%8B%E0%A6%AE%E0%A6%BECategory:MedulloblastomaMeduloblastomMedulloblastomMedulloblastomaMeduloblastomaMedulloblastomaMedulloblastoma%E9%AB%84%E8%8A%BD%E8%85%ABMedulloblastoomRdzeniakMeduloblastoma%D0%9C%D0%B5%D0%B4%D1%83%D0%BB%D0%BB%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0%E0%AE%9A%E0%AE%BF%E0%AE%B1%E0%AF%81_%E0%AE%AE%E0%AF%82%E0%AE%B3%E0%AF%88_%E0%AE%AA%E0%AF%81%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8DU_nguy%C3%AAn_t%E1%BB%A7y_b%C3%A0oQ1333608%E6%88%90%E7%A5%9E%E7%BB%8F%E7%AE%A1%E7%BB%86%E8%83%9E%E7%98%A4
about
sameAs
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsCytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients With Newly Diagnosed WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent MedulloblastomaBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsAuto Transplant for High Risk or Relapsed Solid or CNS Tumorsp28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsTPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaVorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous SystemStudy Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsEGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsPositron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsProton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or PineoblastomaComparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaTreatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorRadiation Therapy Plus Combination Chemotherapy in Treating Children With MedulloblastomaExploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsHyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk MedulloblastomaMetronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive MedulloblastomaAflac ST0901 CHOANOME - Sirolimus in Solid TumorsVismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaYoga Therapy in Treating Patients With Malignant Brain TumorsBiomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and ChemotherapyVolitinib in Treating Participants With Recurrent or Refractory Primary CNS TumorsHER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsPhase I Study of APX005M in Pediatric CNS TumorsTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaHSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsFimepinostat in Treating Brain Tumors in Children and Young AdultsUlixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have SurgeryA Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsStudy of Tomotherapy HD in MedulloblastomaSJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsLow-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed MedulloblastomaRare CNS Tumors Outcomes &RiskOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
P1050
brain stem medulloblastomalarge cell medulloblastomacerebellar vermis medulloblastomaadult medulloblastomamelanotic medulloblastomachildhood medulloblastomanodular medulloblastomaintracranial primitive neuroectodermal tumorspinal cord primitive neuroectodermal neoplasmneuroblastic tumorrelapsed medulloblastomaFAP associated medulloblastomadesmoplastic medulloblastomamedulloblastoma with leptomeningeal spreadprimitive neuroectodermal tumor of the corpus utericlassic medulloblastomamedullomyoblastoma
P279
Daoy1580WUAGPNBO-101CHLA-01-MEDCHLA-01R-MEDCHLA-10CHLA-218CHLA-25CHLA-258CHLA-259CHLA-32CHLA-57CHLA-9COG-E-352D283 MedD341 MedD384 MedD425 MedD458 MedD487 MedD556 MedD581 MedD721 MedDEVFU-PNET-3FU-PNET-4FU-RPNT-1FU-RPNT-2HD-MB03IARC-186IPNN-8MadsenMCD-1MED-MEB-8AMED-MEB-8SMHH-MED-1MHH-MED-2MHH-MED-3MHH-MED-4
P5166
Role of MXD3 in proliferation of DAOY human medulloblastoma cellsPediatric medulloblastoma - update on molecular classification driving targeted therapiesMedulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8Chemotherapy for children with medulloblastomaChemotherapy for children with medulloblastomaVoltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsApoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastomaMass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOYNeuralized1 causes apoptosis and downregulates Notch target genes in medulloblastomaThe SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastomaIdentification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cellsCombined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseasePredominant expression of human zic in cerebellar granule cell lineage and medulloblastomaOxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cellsDeregulated expression of PAX5 in medulloblastomaTreatment of medulloblastoma with a modified measles virusMolecular subgroups of medulloblastoma: the current consensusDual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of MedulloblastomaDissecting the genomic complexity underlying medulloblastomaDifferential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysisThe miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastomaBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveContribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesisInhibition of medulloblastoma cell invasion by SlitIncreased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virusIn vitro models of medulloblastoma: Choosing the right tool for the jobMedulloblastoma stem cells: Promising targets in medulloblastoma therapyEnergy metabolism in neurodevelopment and medulloblastomaTargeting the Hedgehog Pathway in Pediatric MedulloblastomaThe role of the ubiquitin proteasome system in cerebellar development and medulloblastomaAdvances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumorsMedulloblastoma-biology and microenvironment: a reviewMedulloblastoma presenting with pure word deafness: report of one case and review of literatureAdaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastomaCross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceEcto-5'-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma ModelEphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma.MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastomaMicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastomaSmoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
P921
Q61707428-4D1F3659-E383-4A70-8188-5C4223DAF1A2Q61865052-DECF18D4-85C0-4505-8C9C-B6520613A7C2Q61904929-7024ADFB-4401-4134-BE3D-C2FA2081107EQ61915079-1D3B71DD-2158-45BC-BCC4-0D0F137684C6Q61934710-1D56E231-FAE0-4463-8456-F48A1DB0BE75Q61938124-999F7502-5BDC-49F5-B18E-3670214E7E37Q61957088-2697EA7D-9E55-426B-B4DB-896DB14F63B0Q61974984-3616B387-35D8-4FD6-852C-3FE29BD41FECQ61980884-D737660D-4A89-438C-A1B2-03B7E43BA982Q61980918-7653AEDB-FA7E-47B4-92A7-5A98D9B0CD82Q62042214-965009A5-9F59-4540-B94F-F1FCEA6EE641Q62063143-36D30D69-DFC9-4A33-9006-E9CF9C2D326BQ62105305-DBD3BA4A-741D-452A-832F-FB60D1CE54D1Q62105774-97E10CFA-CB6B-49A6-B52D-10F1910D1395Q62110645-7387C42E-1C2E-4CF0-A7D1-DB82CF0803ECQ62110702-465F5AD3-EDD7-430A-B644-0DA5E2DC6C29Q62110997-81659903-5B07-48CE-818B-8D1AD5ED239EQ63321689-3C483B11-167F-455E-BAE1-03568522F245Q63334381-427AD48D-69E5-4471-9BB7-3897F97009A1Q63336838-5CD60ABB-B19E-4434-A94F-B60CCA308C5DQ63337746-AC991C89-1ADF-429E-8DA7-FD9344C843E0Q63340395-5A90B34F-FE47-4D2C-B315-56E0E7CDDD20Q63340802-EA47C9FD-CF26-4FF0-963F-F1E5375D123AQ63340915-80BF4133-8F09-441E-BB33-676494DC323DQ63394355-04270C7B-83AD-4EB1-9CF6-46FB8F7A465AQ63399090-A3851171-4985-4618-9BFB-EBC0545F5BEEQ63405357-FA608A20-6499-478F-B254-D9389EB64ADDQ63573228-58BB3A36-4526-447A-A859-952E4584AA8DQ63576593-D485E75E-D855-4BAF-8D41-41A8F32D0EB1Q63579244-2F06E18A-B677-4336-B3F6-C34E3A1F5AD8Q63579853-672EFC41-313B-466C-BB30-B5986AAA462AQ63587860-50B08BDA-312D-4073-999A-3C7CBE3831D5Q63588038-44BBDB52-E436-4EC9-AB7E-500EC58BD969Q63596278-FABCEAA4-9D98-4219-801C-55A14FF34EC2Q63597267-0AA7C63B-6219-462C-810A-92CF4A9F11E7Q63613451-A760B532-24AB-455D-BB07-F566F437B709Q63804978-C645BA05-6866-4C96-8B6E-76643A1F6674Q63807707-3D99C378-C2B6-46DA-9C81-B710E2CD6FB0Q63807711-D515C781-0E6D-495C-8F93-56874DB3B457Q63807717-98F1DB7B-7304-4E34-A2B1-9B040137FDD3
P1050
Q18553545-37FA0197-91F6-49A7-96FB-2514FC8DD639Q18556095-2EBA6B33-DC33-40F1-81D5-04852A2E5C79Q18556097-219A61AE-A033-46A3-A9C7-4A7B20C3D224Q18556099-0B458548-956E-4803-842E-4A9D5B8E4656Q18556101-07C4F71F-43B2-4011-A426-8ADDB7B28AEDQ18556102-F493B453-D120-4791-951F-A11711447FF7Q18556104-E08F5ED4-903E-4602-8363-62765CD9F78AQ18556482-3CD49D1B-F020-4837-BF58-4DD39BA40327Q18557393-74402B49-6B75-4658-8185-9F1CB781DD21Q18975102-1CBD077A-14BB-40AB-BFD7-41D98464D7A1Q18975641-8595863d-44a0-670e-c767-d4e93d78550eQ18975643-470310ad-4122-103c-8f31-96930ec129a0Q18975647-9f4fc001-414d-f3a7-c781-7524126ead9aQ18975650-a201e3ec-446b-8195-a1a7-81c061aa268bQ55786094-DC20C37E-410C-4D31-9633-F15C4DA0F26EQ56013880-87e46f87-4fd0-a3af-934f-f4a67421aa24Q9304843-79AF66F4-7E9E-4057-8CEE-208D94D31530
P279
description
bösartiger embryonaler Tumor des Kleinhirns
@de
infratentorial cancer located ...... rimitive neuroectodermal tumor
@en
infratentoriell kreft som sit i den nedre delen av hjernen; type nevroektodermal svulst
@nn
nádorové onemocnění
@cs
tumore cerebrale maligno più frequente nell'infanzia
@it
name
Medulloblastom
@de
Medulloblastoma
@hu
Medulloblastoom
@nl
Meduloblastom
@cs
Meduloblastoma
@es
Meduloblastoma
@pt
Rdzeniak
@pl
U nguyên tủy bào
@vi
amir
@fa
medulloblastom
@nn
type
label
Medulloblastom
@de
Medulloblastoma
@hu
Medulloblastoom
@nl
Meduloblastom
@cs
Meduloblastoma
@es
Meduloblastoma
@pt
Rdzeniak
@pl
U nguyên tủy bào
@vi
amir
@fa
medulloblastom
@nn
altLabel
CNS PNET
@en
CPNET
@en
Neuroectodermal Neoplasm
@en
Neuroectodermal Tumor
@en
Neuroepithelioma
@en
PNET
@en
Primitive Neuroectodermal Neoplasm
@en
Primitive Neuroectodermal Tumor (PNET)
@en
Primitive Neuroectodermal Tumor
@en
brain medulloblastoma
@en
prefLabel
Medulloblastom
@de
Medulloblastoma
@hu
Medulloblastoom
@nl
Meduloblastom
@cs
Meduloblastoma
@es
Meduloblastoma
@pt
Rdzeniak
@pl
U nguyên tủy bào
@vi
amir
@fa
medulloblastom
@nn
P1748
P2892
P672
P486
P5806
P6366
P646
P672
P1748
P18
P1995
P2293
P2892
P3417
Medulloblastoma
P373
Medulloblastoma
P3827
medulloblastoma